Profil
Michael Stowell is the founder of AmideBio LLC, where he currently holds the title of Chief Scientific Officer & Director since 2009.
He was a Scientific Advisor at Clarimedix, Inc. and a Professor at The University of Colorado.
Dr. Stowell received his undergraduate degree from The Reed Institute and his doctorate from the California Institute of Technology.
Postes actifs de Michael Stowell
| Sociétés | Poste | Début |
|---|---|---|
AmideBio LLC
 AmideBio LLC BiotechnologyHealth Technology AmideBio LLC operates as a preclinical stage biotech company pursuing a series of therapeutic targets and diagnostic in the diabetes space. Its products include amyloid peptides, amyloid kits & buffers, brazzeins, toxins and knottins. The company was founded by Mikhail Plam and Michael H. B. Stowell and is headquartered in Louisville, CO. | Fondateur | 01/01/2009 |
Anciens postes connus de Michael Stowell
| Sociétés | Poste | Fin |
|---|---|---|
| The University of Colorado | Corporate Officer/Principal | - |
Clarimedix, Inc.
 Clarimedix, Inc. Medical SpecialtiesHealth Technology Clarimedix, Inc. develops pipeline products for diseases associated with vascular dysfunction. It offers products for the treatment of cerebral vasospasm, raynaud’s syndrome and alzheimer’s disease. Clarimedix was founded in 2006 and was headquartered in Aurora, CO. | Corporate Officer/Principal | - |
Formation de Michael Stowell
| The Reed Institute | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Clarimedix, Inc.
Clarimedix, Inc. Medical SpecialtiesHealth Technology Clarimedix, Inc. develops pipeline products for diseases associated with vascular dysfunction. It offers products for the treatment of cerebral vasospasm, raynaud’s syndrome and alzheimer’s disease. Clarimedix was founded in 2006 and was headquartered in Aurora, CO. | Health Technology |
AmideBio LLC
AmideBio LLC BiotechnologyHealth Technology AmideBio LLC operates as a preclinical stage biotech company pursuing a series of therapeutic targets and diagnostic in the diabetes space. Its products include amyloid peptides, amyloid kits & buffers, brazzeins, toxins and knottins. The company was founded by Mikhail Plam and Michael H. B. Stowell and is headquartered in Louisville, CO. | Health Technology |
